Selpercatinib
Especificaciones
2152628-33-4Número CAS
843-660-2Número CE
6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrileNombre IUPAC
C29H31N7O3Fórmula química
525.6 g/molPeso molecular
Selpercatinib; 2152628-33-4; Retevmo; 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile; CEGM9YBNGD; LY3527723; Ret inhibitor loxo-292; DTXSID901026442; WHO 10967; 6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxypyridin-3-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyridin-3-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile; LY-3527723; 6-(2-hydroxy-2-methylpropoxy)-4-(6-{6-[(6-methoxypyridin-3-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl}pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile; 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo(3.1.1)heptan-3-yl)pyridin-3-yl)pyrazolo(1,5-a)pyridine-3-carbonitrile; Pyrazolo(1,5-a)pyridine-3-carbonitrile, 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxy-3-pyridinyl)methyl)-3,6-diazabicyclo(3.1.1)hept-3-yl)-3-pyridinyl)-; selpercatinibum; RefChem:58689; RET Kinase Inhibitor LOXO-292; DTXCID001510634; 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo(3.1.1)heptan-3-yl)pyridin-3-yl)pyrazolo(1,5-a)pyridine-3-carbonitril; 843-660-2; Loxo-292; LOXO292; 6-(2-Hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrile; US10112942, Example 166; Selpercatinib [INN]; Selpercatinib [USAN]; Serpercatinib; Retevmo (TN); MFCD31814089; UNII-CEGM9YBNGD; Selpercatinib (Standard); LOXO-292; Selpercatinib; Selpercatinib [USAN:INN]; Selpercatinib(LOXO-292); Selpercatinib (LOXO-292); Selpercatinib(LOXO-292)?; orb1299110; CHEMBL4559134; SCHEMBL20071478; SCHEMBL29349774; SCHEMBL29362388; Selpercatinib (JAN/USAN/INN); GTPL10318; CPD2206; BDBM296429; BDBM296432; GLXC-21357; GLXC-21860; HMS5086P13; EX-A2859; EBC-27276; NSC818434; s8781; ZB1574; US10112942, Example 163; US10112942, Example 183; AKOS037649115; HY-114370R; NSC-818434; AC-31588; BP-44049; BS-16622; DA-57785; Selpercatinib (LOXO-292, ARRY-192); example 163 [WO2018071447A1]; HY-114370; CS-0084279; T8222; D11713; D77980; EN300-27032767; 6-(2-hydroxy-2- methylpropoxy)-4-(6- (6-((5- methoxypyridin-2- yl)methyl)-3,6- diazabicyclo[3.1.1] heptan-3-yl)pyridin-3- yl)pyrazolo[1,5- a]pyridine-3- carbonitrile; 6-(2-hydroxy-2-methyl-propoxy)-4-[6-[6-[(6-methoxy-3-pyridyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridyl]pyrazolo[1,5-a]pyridine-3-carbonitrile; 6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]-3-pyridinyl]pyrazolo[1,5-a]pyridine-3-carbonitrile; Selpercatinib; Pyrazolo[1,5-a]pyridine-3-carbonitrile, 6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]-; 6-(2-Hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hepSinónimos
Productos que contienen Selpercatinib
레테브모정80밀리그램(셀퍼카티닙)레테브모정40밀리그램(셀퍼카티닙)레테브모캡슐40밀리그램(셀퍼카티닙)레테브모캡슐80밀리그램(셀퍼카티닙)RETSEVMO 80 MG CAPSULAS DURASRETSEVMO 40 MG CAPSULAS DURASRETSEVMO 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULARETSEVMO 80 mg CAPSULAS DURASRETSEVMO 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULARETSEVMO 40 mg CAPSULAS DURASRETSEVMO 80 mg, géluleRETSEVMO 80 mg, comprimé pelliculé
Página 1 de 2
